Literature DB >> 12122913

The rational management of fibromyalgia patients.

Robert M Bennett1.   

Abstract

The exponential increase in pain research over the last 10 years has established fibromyalgia (FM) as a common chronic pain syndrome with similar neurophysiologic aberrations to other chronic pain states. As such, the pathogenesis is considered to involve an interaction of augmented sensory processing (central sensitization) and peripheral pain generators. The notion, that FM symptomatology results from an amplification of incoming sensory impulses, has revolutionized the contemporary understanding of this enigmatic problem and provided a more rational approach to treatment. To date, the management of FM has been mainly palliative, with the aims of reducing pain, improving sleep, maintaining function, treating psychologic distress and diminishing the impact of associated syndromes. The rapidly evolving neurophysiologic, psychophysiologic and molecular biologic basis for chronic pain states has already opened up new avenues for management which should be applicable to this difficult group of patients. Indeed, it is now possible to think about a "rational" approach to managing FM patients that was unthinkable just a few years ago.

Entities:  

Mesh:

Year:  2002        PMID: 12122913     DOI: 10.1016/s0889-857x(02)00002-9

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

1.  Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes.

Authors:  Kay M Johnson; Katharine A Bradley; Kristen Bush; Carolyn Gardella; Dorcas J Dobie; Mary B Laya
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

2.  Is fibromyalgia a cause of failure in the treatment of a painful shoulder?

Authors:  D Blonna; E Bellato; E Marini; N Barbasetti; L Mattei; F Fissore; C Arrigoni; F Castoldi
Journal:  Musculoskelet Surg       Date:  2013-04-16

Review 3.  Management of fibromyalgia.

Authors:  Ashwin A Patkar; Louai Bilal; Prakash S Masand
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

4.  Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial.

Authors:  Antonella Fioravanti; Giuseppe Perpignano; Giuseppe Tirri; Gabriella Cardinale; Chiara Gianniti; Cosima Elvira Lanza; Antonello Loi; Enrico Tirri; Paolo Sfriso; Franco Cozzi
Journal:  Rheumatol Int       Date:  2007-05-23       Impact factor: 2.631

Review 5.  Pharmacologic treatment of fibromyalgia.

Authors:  Kathryn Baker; Andre Barkhuizen
Journal:  Curr Pain Headache Rep       Date:  2005-10

6.  Dynamic mechanical assessment of muscle hyperalgesia in humans: the dynamic algometer.

Authors:  Sara Finocchietti; Thomas Graven-Nielsen; Lars Arendt-Nielsen
Journal:  Pain Res Manag       Date:  2015 Jan-Feb       Impact factor: 3.037

7.  A novel comparative effectiveness study of Tai Chi versus aerobic exercise for fibromyalgia: study protocol for a randomized controlled trial.

Authors:  Chenchen Wang; Timothy McAlindon; Roger A Fielding; William F Harvey; Jeffrey B Driban; Lori Lyn Price; Robert Kalish; Anna Schmid; Tammy M Scott; Christopher H Schmid
Journal:  Trials       Date:  2015-01-30       Impact factor: 2.279

8.  Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study.

Authors:  Heidi K Lempp; Stephani L Hatch; Serene F Carville; Ernest H Choy
Journal:  BMC Musculoskelet Disord       Date:  2009-10-07       Impact factor: 2.362

9.  Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial.

Authors:  Simone Azevedo de Zanette; Rafael Vercelino; Gabriela Laste; Joanna Ripoll Rozisky; André Schwertner; Caroline Buzzatti Machado; Fernando Xavier; Izabel Cristina Custódio de Souza; Alicia Deitos; Iraci L S Torres; Wolnei Caumo
Journal:  BMC Pharmacol Toxicol       Date:  2014-07-23       Impact factor: 2.483

Review 10.  Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes.

Authors:  Ethan B Russo
Journal:  Cannabis Cannabinoid Res       Date:  2016-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.